INC Research is expanding its management team, adding two executives with a focus on the central nervous system (CNS).
Michael Gibertini joins INC, a contract research organization, as vice president for CNS and lead the CNS division. He worked most recently at Organon, dealing primarily with potential treatments for depression and schizophrenia.
Thomas Schlagheck will serve as senior director of CNS scientific affairs. Schlagheck has worked at Eastman Kodak, Procter and Gamble, Algos Pharmaceuticals and Endo Pharmaceuticals. He also is a consultant for clinical development processes.